Mckesson Medical-Surgical Inc. Corporate Office: Drug Recall

Recall #D-1070-2022 · 04/13/2022

Class II: Risk

Recall Details

Recall Number
D-1070-2022
Classification
Class II
Product Type
Drug
Recalling Firm
Mckesson Medical-Surgical Inc. Corporate Office
Status
Terminated
Date Initiated
04/13/2022
Location
Richmond, VA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
983 cartons/1 vial each and 107 cartons/25 vials each

Reason for Recall

cGMP deviations: Temperature abuse

Product Description

MethyLPREDNISolone Acetate Injectable Suspension, USP, 40 mg/mL, packaged in a) 1 mL single dose vial (NDC 0703-0031-01), b) 25-count box (NDC 0703-0031-04), Rx only, MFG: Teva Pharma USA

Distribution Pattern

USA nationwide.

Other Recalls by Mckesson Medical-Surgical Inc. Corporate Office

View all recalls by Mckesson Medical-Surgical Inc. Corporate Office →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.